R&D channel feed

Roche heads to FDA with Gazy­va re­sults in a form of lu­pus

5 months ago

Ku­ra's AML drug pass­es key study in ad­vanced pa­tients, plans next steps with FDA and new­ly di­ag­nosed stud­ies

5 months ago

Small per­son­al­ized vac­cine tri­al sees progress in late-stage kid­ney can­cer

5 months ago

Eye­Point shares more mid-stage da­ta for ther­a­py try­ing to com­pete with Re­gen­eron's Eylea

5 months ago
Pharma

Am­gen an­nounces hold on Phase 1 obe­si­ty can­di­date, pipeline cuts

5 months ago
Pharma

Af­ter re­launch, Roche gets FDA ap­proval for oc­u­lar im­plant in di­a­bet­ic mac­u­lar ede­ma

5 months ago
FDA+

New study will try to stop Alzheimer’s decades be­fore it be­gins, us­ing ex­per­i­men­tal Eli Lil­ly drug

5 months ago

Gene-edit­ed pig kid­neys to be test­ed in more hu­mans soon, two com­pa­nies say

5 months ago

Bio­gen’s re­vised re­search strat­e­gy is to avoid be­com­ing ob­so­lete, top ex­ec says

5 months ago
Deals
China

Irish start­up re­ports mid-stage vic­to­ry for short-act­ing psy­che­del­ic drug in de­pres­sion

5 months ago

Drug­mak­ers seize on bio­mark­ers to test the FDA's rare dis­ease shift

5 months ago
FDA+
In Focus

Ex­clu­sive: Ger­man biotech de­clares Phase 2 win for non-opi­oid drug for neu­ro­path­ic pain

5 months ago

Dai­ichi Sankyo taps new CEO, aims to build up ADC fran­chise

5 months ago
People

Car­go Ther­a­peu­tics cuts lead CAR-T pro­gram, 50% of staff

5 months ago
People
Cell/Gene Tx

Tec­ton­ic gets Phase 1b win in heart con­di­tion where Eli Lil­ly re­cent­ly failed

5 months ago

Mer­ck stops an­oth­er Win­re­vair study ear­ly based on pos­i­tive re­sults from ear­li­er PAH tri­al

5 months ago

Roche aims for de­risked deals and ruth­less port­fo­lio cuts in 2025

5 months ago
Deals

In­hibikase shelves Parkin­son’s as­set af­ter Phase 2 flop

5 months ago

Ex­clu­sive: Fer­til­i­ty start­up to be­gin Phase 3 study of stem cell ther­a­py for IVF

5 months ago
FDA+

Ahead of earn­ings, Lil­ly culls mid-stage drug for heart fail­ure and chron­ic kid­ney dis­ease

5 months ago
Pharma

Leap Ther­a­peu­tics treks to­ward piv­otal study in col­orec­tal can­cer, drops gas­tric can­cer

5 months ago

ITM aims to com­pete with No­var­tis af­ter Phase 3 ra­dio­phar­ma win

5 months ago

Sarep­ta shares two-year DMD study da­ta that could in­form Eu­ro­pean ap­proval de­ci­sion

5 months ago
Pharma
FDA+

Bris­tol My­ers shares IO com­bo da­ta in col­orec­tal can­cer; Pfiz­er still wait­ing on Braftovi reg­i­men sur­vival fig­ures

5 months ago
Pharma
First page Previous page 14151617181920 Next page Last page
A service from the Financial Times